Zobrazeno 1 - 10
of 75
pro vyhledávání: '"N. Somoza"'
Autor:
Karina M Rompato, Susana N Somoza
Publikováno v:
Biotecnología Aplicada, Vol 32, Iss 4, Pp 4221-4227
Externí odkaz:
https://doaj.org/article/a15746034ef446c4b6e608487d9807a0
Autor:
N. Somoza, I. Burns, L. Resegotti, C. Bernasconi, A. Van Der Merwe, A. Erazo Valla, H. Morioka, J. Lardinois, J.C. Diaz-Maqueo, A. Ho, J.A. Moreno-Nogueira, E. Richards, S. Pavlovsky, R.B. Rastogi, H. Rueckle, W. Bezwoda
Publikováno v:
European Journal of Cancer. 31:903-911
59 previously untreated patients with intermediate- or high-grade, stage II–IV non-Hodgkin's lymphoma (NHL) were entered into an open-label, randomised, multicentre study to compare the efficacy and safety of CHOP (cyclophosphamide, doxorubicin, vi
Autor:
N Somoza, F Vargas, C Roura-Mir, M Vives-Pi, M T Fernández-Figueras, A Ariza, R Gomis, R Bragado, M Martí, D Jaraquemada
Publikováno v:
The Journal of Immunology. 153:1360-1377
Insulin-dependent diabetes mellitus (IDDM), in which only the pancreatic beta cells are destroyed by the autoimmune response, is the paradigm of organ-specific autoimmunity. As a result of a combination of factors, the number of immunohistologic/cell
Publikováno v:
The Journal of Urology. :306-308
Publikováno v:
Diabetes. 40:1382-1390
Autor:
F, Vargas, M, Vives-Pi, N, Somoza, P, Armengol, L, Alcalde, M, Martí, M, Costa, L, Serradell, O, Dominguez, J, Fernández-Llamazares, J F, Julian, A, Sanmartí, R, Pujol-Borrell
Publikováno v:
Transplantation. 65(5)
Clinical transplantation of human islets has a disappointingly low rate of success. We report here the identification of a possible causative factor: endotoxin present in the collagenase preparations used to disperse the pancreatic tissue before isle
Autor:
F, Vargas, M, Vives-Pi, N, Somoza, L, Alcalde, P, Armengol, M, Martí, L, Serradell, M, Costa, J, Fernandez-Llamazares, A, Sanmartí, R, Pujol-Borrell
Publikováno v:
Transplantation. 61(11)
Human islet transplantation has a high rate of failure, often due to primary nonfunction, which suggests that islets are damaged during the processing of the pancreas. The preparation of human islets for transplantation is still a complex process tha
Autor:
W, Bezwoda, R B, Rastogi, A, Erazo Valla, J C, Diaz-Maqueo, S, Pavlovsky, H, Morioka, L, Resegotti, H, Rueckle, N, Somoza, J A, Moreno-Nogueira
Publikováno v:
European journal of cancer (Oxford, England : 1990). (6)
59 previously untreated patients with intermediate- or high-grade, stage II-IV non-Hodgkin's lymphoma (NHL) were entered into an open-label, randomised, multicentre study to compare the efficacy and safety of CHOP (cyclophosphamide, doxorubicin, vinc
Autor:
S, Pavlovsky, G, Milone, N, Somoza, C, Corrado, H, Magnasco, I, Cerutti, J, Saslavsky, I, Fernández, S, Bruno
Publikováno v:
Sangre. 38(1)
To compare four first generation chemotherapy regimes (FGR) used by GATLA in low and intermediate grade lymphomas. Versus a second generation regimen called CAVPE.A group of 205 patients treated with FGR (79 with BACOP, 89 with COPP, 19 with CHOP, an
Autor:
Santiago Pavlovsky, N. Somoza, E. L. Garcia Vela, A. Erazo, J. C. Diaz Maqueo, Claudia Corrado, G. Cervantes, M. Lluesma Goñalons, M. T. Santarelli, G. Milone, H. Magnasco
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 3(3)
A randomized multicenter phase III study was conducted to compare the efficacy and toxicity of CHOP and CNOP in intermediate and high-grade non-Hodgkin's lymphoma. CHOP consisted of cyclophosphamide 750 mg/m2, vincristine 1.4 mg/m2, doxorubicin 50 mg